Literature DB >> 15708870

Prevalence of ischaemic heart disease at admission to intensive care and its influence on red cell transfusion thresholds: multicentre Scottish Study.

T S Walsh1, D B McClelland, R J Lee, M Garrioch, C R Maciver, F McArdle, S L Crofts, I Mellor.   

Abstract

BACKGROUND: Restrictive transfusion triggers are safe for most critically ill patients, but doubts exist for patients with ischaemic heart disease (IHD). We investigated the prevalence of reported IHD at admission to the intensive care unit (ICU) and investigated how this influenced red cell transfusion triggers. We also compared observed practice with the clinicians' responses to clinical scenarios.
METHODS: We studied 1023 sequential ICU admissions over 100 days to 10 Scottish ICUs. Daily haemoglobin, red cell transfusion, and haemorrhage data were available for 99.4% of 5638 ICU patient days. We recorded if IHD was recorded in clinical records at ICU admission. We grouped admissions as having a non-cardiac primary ICU diagnosis and no documentary evidence of IHD (Group 1, n=697), a non-cardiac primary ICU diagnosis with evidence of IHD (Group 2, n=213), or a cardiac primary ICU admission diagnosis (Group 3, n=113). We examined pre-transfusion haemoglobin concentration (Hb) for transfusion episodes not associated with haemorrhage. Clinical transfusion scenarios were sent to intensivists in the ICUs after data collection, which were designed to explore the clinicians' attitude to transfusion triggers in patients with IHD.
RESULTS: Previous myocardial infarction was documented in 159 (16%), cardiac failure in 142 (14%), and angina in 167 (16%). Overall, 28.8% of admissions had >/=1 of these documented. The adjusted mean (se) pre-transfusion Hb concentrations varied across the groups. These were 74 (2.2) g litre(-1) in Group 1, 77 (2.3) g litre(-1) in Group 2, and 79 (3.1) g litre(-1) in Group 3 (P=0.003 across the groups). There was concordance between observed practice and responses to the scenario similar to Group 1, but discordance for patients with IHD (Groups 2 and 3). In scenario responses, intensivists stated these patients should have significantly higher transfusion triggers than were actually observed (median [IQR] response for both groups: 90 [80-100] g litre(-1)).
CONCLUSIONS: About 29% of patients admitted to Scottish ICUs had documented IHD, which was associated with small adjustments to Hb transfusion triggers. In response to scenarios, clinicians believe that patients with IHD require higher transfusion triggers than are observed in practice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708870     DOI: 10.1093/bja/aei073

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  12 in total

1.  Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice.

Authors:  Timothy S Walsh; Robert J Lee; Caroline R Maciver; Magnus Garrioch; Fiona Mackirdy; Alexander R Binning; Stephen Cole; D Brian McClelland
Journal:  Intensive Care Med       Date:  2005-11-23       Impact factor: 17.440

2.  Determinants of transfusion decisions in a mixed medical-surgical intensive care unit: a prospective cohort study.

Authors:  Alexander P J Vlaar; Anne L In der Maur; Jan M Binnekade; Marcus J Schultz; Nicole P Juffermans
Journal:  Blood Transfus       Date:  2009-04       Impact factor: 3.443

Review 3.  [Erythrocyte transfusion: update of the guidelines "therapy with blood components and plasma derivatives"].

Authors:  M Welte
Journal:  Anaesthesist       Date:  2009-11       Impact factor: 1.041

4.  1 RBC Concentrates.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

5.  Red blood cell transfusion in the critically ill patient.

Authors:  Christophe Lelubre; Jean-Louis Vincent
Journal:  Ann Intensive Care       Date:  2011-10-04       Impact factor: 6.925

6.  A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time.

Authors:  Simon J Stanworth; Timothy S Walsh; Robin J Prescott; Robert J Lee; Douglas M Watson; Duncan Wyncoll
Journal:  Crit Care       Date:  2011-04-05       Impact factor: 9.097

7.  Using theories of behaviour to understand transfusion prescribing in three clinical contexts in two countries: development work for an implementation trial.

Authors:  Jill J Francis; Alan Tinmouth; Simon J Stanworth; Jeremy M Grimshaw; Marie Johnston; Chris Hyde; Charlotte Stockton; Jamie C Brehaut; Dean Fergusson; Martin P Eccles
Journal:  Implement Sci       Date:  2009-10-24       Impact factor: 7.327

8.  A prospective study of the impact of serial troponin measurements on the diagnosis of myocardial infarction and hospital and six-month mortality in patients admitted to ICU with non-cardiac diagnoses.

Authors:  Marlies Ostermann; Jessica Lo; Michael Toolan; Emma Tuddenham; Barnaby Sanderson; Katie Lei; John Smith; Anna Griffiths; Ian Webb; James Coutts; John Chambers; Paul Collinson; Janet Peacock; David Bennett; David Treacher
Journal:  Crit Care       Date:  2014-04-04       Impact factor: 9.097

9.  Savoring every drop - vampire or mosquito?

Authors:  Dania Patricia Fischer; Kai D Zacharowski; Patrick Meybohm
Journal:  Crit Care       Date:  2014-05-21       Impact factor: 9.097

10.  Unrecognised myocardial infarction and its relationship to outcome in critically ill patients with cardiovascular disease.

Authors:  Annemarie B Docherty; Shirjel Alam; Anoop S Shah; Alastair Moss; David E Newby; Nicholas L Mills; Simon J Stanworth; Nazir I Lone; Timothy S Walsh
Journal:  Intensive Care Med       Date:  2018-10-29       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.